EUVIMEDEUVIMED entdecken
Crossref

Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI

Ida Sonni, Adam B Weiner, Sahith Doddipalli, Madhvi Deol, David Ban, Hye Ok Kim, Tristan Grogan, Preeti Ahuja, Nashla Barroso, Yang Zong, Priti Soin, Anthony Sisk und 5 weitere

Journal of Nuclear Medicine · 30.10.2024 · jnumed.124.268443

DOI: 10.2967/jnumed.124.268443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 30.10.2024. Verfasst von Ida Sonni und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiological Sciences, UCLA, Los Angeles, California; isonni@mednet.ucla.edu. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging, Glutamate Carboxypeptidase II. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiparametric MRI (mpMRI) and prostate-specific membrane antigen (PSMA) PET/CT are complementary imaging modalities used in the presurgical evaluation of patients with prostate cancer (PCa). The purpose of this study was to characterize clinically significant PCa (csPCa) detected and not detected by PSMA PET/CT and mpMRI, focusing on tumors detected solely by PSMA PET/CT and overlooked by mpMRI.

Methods

We conducted a single-center, retrospective analysis of patients who underwent both PSMA PET/CT and mpMRI within 3 mo of each other and before radical prostatectomy. Two nuclear medicine physicians and 2 radiologists, in a masked manner, independently contoured PCa lesions on PSMA PET/CT and mpMRI, respectively. A consensus read was done with a third reader for each modality, and a majority rule was applied (2:1). After centralized imaging, a pathologic review was done by a genitourinary pathologist. We assessed agreement between imaging modalities and correlation with pathology. Logistic regression models explored associations between clinicopathologic variables and tumor detection on imaging.

Results

In total, 132 csPCa tumors from 100 patients were identified on surgical pathology. PSMA PET/CT showed higher lesion-level (87% vs. 80%) and patient-level (98% vs. 94%) sensitivity than mpMRI. Tumors detected on both imaging modalities were larger and had higher grade groups than those not detected by one or both imaging modalities. On multivariable analysis, csPCa tumors undetected by mpMRI but detected by PSMA PET/CT were smaller than those detected by both modalities. Most tumors showing aggressive pathologic features, such as the large cribriform pattern (94.7%) and the intraductal carcinoma (96%), were correctly detected by both imaging modalities. Limitations included selection bias in a surgical cohort.

Conclusion

PSMA PET/CT tends to detect smaller csPCa not detected by mpMRI. Larger tumors on pathology with higher grade groups are more likely to be correctly detected by both imaging modalities. These findings provide insights for refining presurgical evaluation strategies in PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyProstatic NeoplasmsMultiparametric Magnetic Resonance ImagingGlutamate Carboxypeptidase IIHumansMaleAgedRetrospective StudiesMiddle AgedAntigens, Surface

Stichwörter der Autor:innen

PSMA PET/CTmultiparametric MRIprostate cancerprostate cancer stagingwhole-mount pathology

Substanzen

Glutamate Carboxypeptidase IIFOLH1 protein, humanAntigens, Surface

Autor:innen und Institutionen

  • Department of Radiological Sciences, UCLA, Los Angeles, California; isonni@mednet.ucla.edu.
  • Department of Experimental and Clinical Medicine, University Magna Graecia, Catanzaro, Italy.
  • Department of Urology, UCLA, Los Angeles, California.
  • Institute for Precision Health, UCLA, Los Angeles, California.
  • Department of Radiological Sciences, UCLA, Los Angeles, California.
  • Department of Medicine Statistics Core, UCLA, Los Angeles, California.

Zitieren

APA

Sonni, I., Weiner, A. B., Doddipalli, S., Deol, M., Ban, D., Kim, H. O., Grogan, T., Ahuja, P., Barroso, N., Zong, Y., Soin, P., Sisk, A., Czernin, J., Hsu, W., Calais, J., Reiter, R. E., & Raman, S. S. (2024). Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI. Journal of Nuclear Medicine, jnumed.124.268443. https://doi.org/10.2967/jnumed.124.268443

Vancouver

Sonni I, Weiner AB, Doddipalli S, Deol M, Ban D, Kim HO, et al. Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI. Journal of Nuclear Medicine. 2024:jnumed.124.268443. doi:10.2967/jnumed.124.268443

BibTeX
@article{Sonni2024,
  author = {Sonni, Ida and Weiner, Adam B and Doddipalli, Sahith and Deol, Madhvi and Ban, David and Kim, Hye Ok and Grogan, Tristan and Ahuja, Preeti and Barroso, Nashla and Zong, Yang and Soin, Priti and Sisk, Anthony and Czernin, Johannes and Hsu, William and Calais, Jeremie and Reiter, Robert E and Raman, Steven S},
  title = {Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  pages = {jnumed.124.268443},
  doi = {10.2967/jnumed.124.268443}
}
Kostenlos starten →